Viewing Study NCT02045602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-02-26 @ 4:19 PM
Study NCT ID: NCT02045602
Status: COMPLETED
Last Update Posted: 2020-10-08
First Post: 2014-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors
Sponsor: Theriva Biologics SL
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Solid Tumors View
None Metastatic Solid Tumors View
None Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Solid Tumors View
None Gemcitabine View
None Oncolytic virus View
None Metastatic View
None Pancreatic cancer View